- Home
- AVIR vs FOA Comparison
AVIR vs FOA Comparison
Compare AVIR & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- FOA
- Stock Information
- Founded
- AVIR 2012
- FOA 2013
- Country
- AVIR United States
- FOA United States
- Employees
- AVIR N/A
- FOA N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- FOA Finance Companies
- Sector
- AVIR Health Care
- FOA Finance
- Exchange
- AVIR Nasdaq
- FOA Nasdaq
- Market Cap
- AVIR 290.4M
- FOA 272.8M
- IPO Year
- AVIR 2020
- FOA N/A
- Fundamental
- Price
- AVIR $3.27
- FOA $21.63
- Analyst Decision
- AVIR Hold
- FOA Buy
- Analyst Count
- AVIR 1
- FOA 2
- Target Price
- AVIR $6.00
- FOA $27.50
- AVG Volume (30 Days)
- AVIR 453.6K
- FOA 118.4K
- Earning Date
- AVIR 11-07-2025
- FOA 11-04-2025
- Dividend Yield
- AVIR N/A
- FOA N/A
- EPS Growth
- AVIR N/A
- FOA N/A
- EPS
- AVIR N/A
- FOA 7.10
- Revenue
- AVIR N/A
- FOA $527,520,999.00
- Revenue This Year
- AVIR N/A
- FOA $21.21
- Revenue Next Year
- AVIR N/A
- FOA $10.95
- P/E Ratio
- AVIR N/A
- FOA $3.02
- Revenue Growth
- AVIR N/A
- FOA 46.94
- 52 Week Low
- AVIR $2.46
- FOA $11.37
- 52 Week High
- AVIR $4.02
- FOA $32.40
- Technical
- Relative Strength Index (RSI)
- AVIR 57.88
- FOA 39.67
- Support Level
- AVIR $3.15
- FOA $22.38
- Resistance Level
- AVIR $3.34
- FOA $23.03
- Average True Range (ATR)
- AVIR 0.10
- FOA 0.80
- MACD
- AVIR 0.02
- FOA 0.10
- Stochastic Oscillator
- AVIR 79.37
- FOA 27.88
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.